The new report by Expert Market Research titled, ‘Global Ambulatory Arrhythmia Monitoring Devices Market Size, Report and Forecast 2022-2027’, gives an in-depth analysis of the global ambulatory arrhythmia monitoring devices market, assessing the market based on its segments like device types, end-users, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
The key highlights of the report include:
Market Overview (2017-2027)
• Forecast CAGR (2022-2027): 6.8%
The global ambulatory arrhythmia monitoring devices market is being driven by the growing healthcare sector in countries across the world. Factors such as the rising healthcare expenditure, rising quality of life, increasing focus on early detection of cardiac diseases, and rising healthcare awareness are positively influencing the market growth. Further, the rising cases of cardiac attacks among geriatrics are likely to boost the demand for ambulatory arrhythmia monitoring devices in the forecast period. Furthermore, the growing efforts by the government in the emerging economies to improve the monitoring and diagnostic capabilities in the healthcare sector are likely to provide impetus to the market in the forecast period.
Industry Definition and Major Segments
Ambulatory arrhythmia monitoring devices refer to the devices which are used in the treatment of chronic cardiac diseases, majorly, arrhythmia. These devices are placed on the left or right side of the chest and have the power to diagnose a potential case of arrhythmia according to the symptoms.
By device type, the market can be segmented into:
• Resting ECG
• Event Monitor
• Implantable Cardiac Monitor
• Holter Monitor
• Mobile Cardiac Telemetry Devices
Based on end-user, the market is segmented into:
• Hospitals and Clinics
• Diagnostic Centres
• Ambulatory Surgical Centres
• Homecare Settings
The regional markets for ambulatory arrhythmia monitoring devices include:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
The market growth is expected to be driven by the rapid technological advancements in the healthcare sector. The rising investments in research and development (R&D) activities are likely to boost the quality of medical equipment in the coming years, which, in turn, is anticipated to stimulate the market growth of ambulatory arrythmia monitoring devices. Moreover, the rapid development of hospitals and ambulatory surgical centres is likely to be another key trend in the market. Geographically, North America accounts for a significant share in the market owing to the strong foothold of major medical device manufacturers in the region and the high healthcare expenditure observed in the United States and Canada.
Key Market Players
The major players in the market are Biotronik, BioTelemetry Inc., Abbott Laboratories, Medi-Lynx Cardiac Monitoring, LLC, and ZOLL Medical Corporation, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.